[PDF] frontiersin.org

Establishment of a novel cytokine-related 8-gene signature for distinguishing and predicting the prognosis of triple-negative breast cancer

X Liu, L Zhang, L Chen - Frontiers in Medicine, 2023 - frontiersin.org
Background Triple-negative breast cancer (TNBC) is a common carcinoma in women, and
the prognosis of TNBC is the worst. Using data from The Cancer Genome Atlas (TCGA) …
相关文章 所有 4 个版本
[HTML] nih.gov

[HTML][HTML] Identification of novel prognostic genes of triple-negative breast cancer using meta-analysis and weighted gene co-expressed network analysis

W Cao, Y Jiang, X Ji, X Guan, Q Lin… - Annals of Translational …, 2021 - ncbi.nlm.nih.gov
Background Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer
with high rates of metastasis and recurrence. Conventional clinical treatments are ineffective …
被引用次数：17 相关文章 所有 7 个版本
[HTML] nih.gov

[HTML][HTML] Identification of a novel signature with prognostic value in triple-negative breast cancer through clinico-transcriptomic analysis

C Chen, CJ Lin, SY Li, X Hu… - Annals of Translational …, 2022 - ncbi.nlm.nih.gov
Background Although perceived as a highly aggressive disease, triple-negative breast
cancer (TNBC) constitutes heterogeneous features with various outcomes. In this study, we …
被引用次数：1 相关文章 所有 6 个版本
[PDF] frontiersin.org

Identification of potential key genes associated with the pathogenesis, metastasis, and prognosis of triple-negative breast cancer on the basis of integrated …

B Zhao, Y Xu, Y Zhao, S Shen, Q Sun - Frontiers in Oncology, 2020 - frontiersin.org
Objective: Breast cancer is the most common solid tumor affecting women and the second
leading cause of cancer-related death worldwide, and triple-negative breast cancer (TNBC) …
被引用次数：5 相关文章 所有 5 个版本
[HTML] nih.gov

[HTML][HTML] Integrated bioinformatic analysis of potential biomarkers of poor prognosis in triple-negative breast cancer

R Bissanum, R Kamolphiwong… - Translational Cancer …, 2022 - ncbi.nlm.nih.gov
Background Triple-negative breast cancer (TNBC) is a heterogeneous disease associated
with late-stage diagnosis and high metastatic rates. However, a gene signature for reliable …
被引用次数：5 相关文章 所有 7 个版本
[PDF] frontiersin.org

Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancer

MS Alam, A Sultana, G Wang… - Frontiers in Molecular …, 2022 - frontiersin.org
Triple-negative breast cancer (TNBC) is one of the most lethal subtypes of breast cancer
(BC), and it accounts for approximately 10%–20% of all invasive BCs diagnosed worldwide …
被引用次数：6 相关文章 所有 8 个版本
[PDF] spandidos-publications.com

Identification of potential oncogenes in triple‑negative breast cancer based on bioinformatics analyses

X Xiao, Z Zhang, R Luo, R Peng, Y Sun… - Oncology …, 2021 - spandidos-publications.com
Triple‑negative breast cancer (TNBC) is a subtype with high rates of metastasis, poor
prognosis and limited therapeutic options. The present study aimed to identify the potential …
被引用次数：8 相关文章 所有 9 个版本
[PDF] frontiersin.org

Transcriptome-based network analysis unveils eight immune-related genes as molecular signatures in the immunomodulatory subtype of triple-negative breast cancer

J Zhang, L Wang, X Xu, X Li, W Guan, T Meng… - Frontiers in …, 2020 - frontiersin.org
Objective: Triple-negative breast cancer (TNBC) is a high heterogeneity cancer. The
identification of genomic aberrations that drive each of the TNBC subtypes may predict the …
被引用次数：35 相关文章 所有 4 个版本
[HTML] nih.gov

[HTML][HTML] Identification of immune-related prognostic biomarkers in triple-negative breast cancer

XQ Song, ZM Shao - Translational Cancer Research, 2024 - ncbi.nlm.nih.gov
Background Triple-negative breast cancer (TNBC), a type of breast cancer, lacks immune-
related markers that can be used for prognosis or prediction. Therefore, we created a …
相关文章 所有 6 个版本

Identification of a Group of Therapeutic Targets and Prognostic Biomarker for Triple Negative Breast Cancer

Y Li, S Yang, L Qi, Y Li, X Wang - Advances in Therapy, 2024 - Springer
Introduction Triple-negative breast cancer (TNBC) is a highly heterogeneous disease.
Mining differentially expressed genes of TNBC is helpful to explore new therapeutic targets …
相关文章 所有 3 个版本